Adicet Bio, Inc. (NASDAQ:ACET) Receives $14.50 Consensus Price Target from Analysts
Shares of Adicet Bio, Inc. (NASDAQ:ACET – Get Free Report) have earned an average rating of “Moderate Buy” from the seven research firms that are presently covering the stock, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month […]
More Stories
Analysts Set Life360, Inc. (NASDAQ:LIF) PT at $44.75
Life360, Inc. (NASDAQ:LIF – Get Free Report) has been assigned a consensus rating of “Buy” from the eight research firms...
Aemetis, Inc. (NASDAQ:AMTX) Given Consensus Recommendation of “Moderate Buy” by Brokerages
Shares of Aemetis, Inc. (NASDAQ:AMTX – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the...
StockNews.com Downgrades Brightcove (NASDAQ:BCOV) to Buy
StockNews.com cut shares of Brightcove (NASDAQ:BCOV – Free Report) from a strong-buy rating to a buy rating in a research...
StockNews.com Upgrades Team (NYSE:TISI) to “Strong-Buy”
StockNews.com upgraded shares of Team (NYSE:TISI – Free Report) from a buy rating to a strong-buy rating in a research...
Chicago Rivet & Machine (NYSEAMERICAN:CVR) Now Covered by Analysts at StockNews.com
StockNews.com began coverage on shares of Chicago Rivet & Machine (NYSEAMERICAN:CVR – Free Report) in a report published on Wednesday...
Aeries Technology (AERT) & Its Competitors Head-To-Head Comparison
Profitability This table compares Aeries Technology and its peers’ net margins, return on equity and return on assets. Net Margins...